Report cover image

Global Single-use Bioreactors Market - 2023-2030

Publisher DataM Intelligence 4Market Research LLP
Published Jan 18, 2024
Length 184 Pages
SKU # DTAM18436757

Description

Global Single-use Bioreactors Market - 2023-2030


Global Single-use Bioreactors market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period 2023-2030.

A single-use bioreactor is a type of bioreactor that uses a disposable bag instead of a culture vessel. This technology allows manufacturers to use disposable bags in the manufacturing process, which was previously only possible with stainless steel equipment. The use of single-use bags helps to minimize the risk of cross contamination and improves the safety of the biological and process. These bioreactors are particularly well-suited for biopharmaceutical products.

Market Dynamics: Drivers & Restraints

Increasing Advanced Products Introductions

The increasing advanced product launches in the market are expected to boost the global market during the forecast period. For instance, in March 2022, Dundee-based Cellexus International launched a single-use airlift bioreactor that permits researchers to grow fragile cell cultures for their investigation more swiftly and cost effectively.

Rather of utilizing intenser mixing procedures, the Cell Maker single-use airlift bioreactors create bubbles that ooze via the blend, yielding a gentle mixing action for even the considerably delicate cell cultures. Moreover, in March 2020, Sartorius Stedim Biotech launched BIOSTAT STR Generation 3 single-use bioreactor and BIOBRAIN automation platform developed to produce biopharmaceutical development and production quickly, more straightforward and securer.

Furthermore, the technological advancements, rise in research activities, increasing investments, growing cases of chronic and heridaitery conditions and increaseing awareness are among the other additional factors boosting the global market growth during the forecast period.

High Frequent Costs

The high frequent costs are anticipated to hamper growth of the single-use bioreactor market. For instance, periodic costs for single-use bioreactors has been encountered to be high, the expense concerned with the waste management of considerable amounts of disposables is also elevated. SUBs cause more additional disposal costs corresponded to reusable units, which already has high upfront costs in terms of installation and upkeep. Furthermore, the lack of skilled professionals and parameter regulation associated concerns are among the additional factors slowing the global market growth during the forecast period.

Segment Analysis

The global single-use bioreactors market is segmented based on product, type, molecule type, cell type, application, end user and region.

Single-use Bioreactors System Product Segment are Expected to Dominate Market

Owing to the increasing market developments such as product launches and investments in the single-use bioreactors system product segment, the segment is expected to dominate the global market during the forecast period. For instance, in January 2023, PBS Biotech, an innovative, single-use bioreactor system manufacturer and process development Single-use Filtration Assemblies provider, secured a $22 million financing led by Avego Management, LLC with further investment from existing investor BroadOak Capital Partners.

This investment is intended to be utilized for enhancing the corporation's development portfolio, extending its process development Single-use Filtration Assemblies capability, and improving customer assistance to global cell therapy clients. Moreover, in January 2019, Sartorius Stedim Biotech (SSB), a top international provider for the biopharmaceutical industry launched the BIOSTAT RM TX single-use bioreactor, a new wave mixed system designed especially for closed, automated expansion of uniform quality cell products like ex vivo cellular immunotherapies.

Geographical Analysis

North America is Expected to Dominate the Global Market

Owing to the presence of key market players holding large share of the global market by performing distinct market tactics in North America, the region is expected to dominate the global market during the forecast period. For instance, in in November 2022, Danaher Corporation's United States-based subsidiary, Cytiva invested about USD 8 million to extend its Fast Trak center in Shanghai, China.

The Single-use Technologies (SUT) Center of Excellence in Asia presents unique development R&D trials and verification intending to promote the industry’s application of SUT throughout the province. Moreover, in August 2022, Thermo Fisher Scientific, a United States-based multinational market leader inaugurated its most extensive single-use technology manufacturing location in Greater Nashville with an investment of USD 105 million to satisfy the increasing demand for the bioprocessing materials required to create vaccines and breakthrough treatments for cancer and other disorders.

COVID-19 Impact Analysis

During the COVID-19 pandemic, the global demand for bioreactors has increased due to their widespread usage in cell culture-based viral vaccine production. This has presented significant growth opportunities for players in the single-use bioreactor market. For instance, ABEC delivered six 4,000L CSR bioreactors to Serum Institute of India in September 2020 to quicken the production of Novavax’ COVID-19 vaccine nominee, NVX CoV2373. In addition, Serum Institute leveraged ABEC’s single-use technology to boost the supply of NVX CoV2373 to low- and middle-income nations.

Market Segmentation

By Product
• Single-use Bioreactors System
• Single-use Media Bag
• Single-use Filtration Assemblies
• Others

By Type
• Bubble Column Single-use Bioreactors
• Stirred Tank Single-use Bioreactors
• Wave Induced Single-use Bioreactors

By Molecule Type
• Monoclonal Antibodies (MABs)
• Vaccine, Stem Cells
• Gene–Modified Cells
• Other Molecules

By Cell Type
• Mammalian Cells
• Bacteria Cells
• Yeast Cells
• Other Cells

By Application
• Research and Development
• Process Development
• Bio production

By End User
• Academic & Research Institutes
• CROs and CMOs
• Pharmaceutical & Biotechnology Companies
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Key Developments
• In November 2022, Sartorius GA, planned to invested in expanding its processes by setting new R&D laboratories and digitalizing & automating equipment, with other courses.
• In December 2022, Merck completed the acquisition of Erbi Biosystems, a Massachusetts-based corporation that develops a 2ml micro bioreactor platform, Breez, intended to strengthen Merck’s upstream portfolio in the therapeutic protein segment.
• In October 2021, Agilitech, a United States-based corporation that delivers simultaneous control of up to two single-use bioreactors from 30 L up to 2000 L launched the Agilitech bioreactor controller.

Competitive Landscape

The major global players in the market include ABEC, Thermo Fisher Scientific, Inc., Sartorius AG, Pall Corporation, Celltainer, Distek, Inc., Merck KGaA, PBS Biotech, Inc., CYTIVA and Eppendorf SE.

Why Purchase the Report?
• To visualize the global single-use bioreactors market segmentation based on product, type, molecule type, cell type, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of single-use bioreactors market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global single-use bioreactors market report would provide approximately 69 tables, 69 figures and 184 pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

184 Pages
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product
3.2. Snippet by Application
3.3. Snippet by Cell Type
3.4. Snippet by Molecule Type
3.5. Snippet by Type
3.6. Snippet by End User
3.7. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Advanced Products Introductions
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. High Frequent Costs
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Pricing Analysis
5.3. Regulatory Analysis
5.4. Patent Analysis
5.5. Technology and Trend Analysis
5.6. Unmet Need
5.7. SWOT Analysis
5.8. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Single-use Bioreactors System*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Single-use Media Bag
7.4. Single-use Filtration Assemblies
7.5. Other
8. By Molecule Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Molecule Type
8.1.2. Market Attractiveness Index, By Molecule Type
8.2. Monoclonal Antibodies (MABs)*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Vaccine, Stem Cells
8.4. Gene–Modified Cells
8.5. Other Molecules
9. By Cell Type
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
9.1.2. Market Attractiveness Index, By Cell Type
9.2. Mammalian Cells*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Bacteria Cells
9.4. Yeast Cells
9.5. Other Cells
10. By Application
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.1.2. Market Attractiveness Index, By Application
10.2. Research and Development*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Process Development
10.4. Bio production
11. By Type
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.1.2. Market Attractiveness Index, By Type
11.2. Bubble Column Single-use Bioreactors*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Stirred Tank Single-use Bioreactors
11.4. Wave Induced Single-use Bioreactors
12. By End User
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.1.2. Market Attractiveness Index, By End User
12.2. Academic & Research Institutes*
12.2.1. Introduction
12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
12.3. CROs and CMOs
12.4. Pharmaceutical & Biotechnology Companies
12.5. Others
13. By Region
13.1. Introduction
13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
13.1.2. Market Attractiveness Index, By Region
13.2. North America
13.2.1. Introduction
13.2.2. Key Region-Specific Dynamics
13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Molecule Type
13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13.2.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.2.9.1. U.S.
13.2.9.2. Canada
13.2.9.3. Mexico
13.3. Europe
13.3.1. Introduction
13.3.2. Key Region-Specific Dynamics
13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Molecule Type
13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13.3.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.3.9.1. Germany
13.3.9.2. UK
13.3.9.3. France
13.3.9.4. Italy
13.3.9.5. Spain
13.3.9.6. Rest of Europe
13.4. South America
13.4.1. Introduction
13.4.2. Key Region-Specific Dynamics
13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Molecule Type
13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13.4.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.4.9.1. Brazil
13.4.9.2. Argentina
13.4.9.3. Rest of South America
13.5. Asia-Pacific
13.5.1. Introduction
13.5.2. Key Region-Specific Dynamics
13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Molecule Type
13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13.5.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.5.9.1. China
13.5.9.2. India
13.5.9.3. Japan
13.5.9.4. Australia
13.5.9.5. Rest of Asia-Pacific
13.6. Middle East and Africa
13.6.1. Introduction
13.6.2. Key Region-Specific Dynamics
13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Molecule Type
13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.6.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
14. Competitive Landscape
14.1. Competitive Scenario
14.2. Market Positioning/Share Analysis
14.3. Mergers and Acquisitions Analysis
15. Company Profiles
15.1. ABEC*
15.1.1. Company Overview
15.1.2. Product Portfolio and Description
15.1.3. Financial Overview
15.1.4. Key Developments
15.2. Thermo Fisher Scientific, Inc.
15.3. Sartorius AG, Inc.
15.4. PALL CORPORATION
15.5. Celltainer
15.6. Distek, Inc.
15.7. Merck KGaA
15.8. PBS Biotech, Inc.
15.9. CYTIVA
15.10. Eppendorf SE
LIST NOT EXHAUSTIVE
16. Appendix
16.1. About Us and Single-use Filtration Assemblies
16.2. Contact Us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us